Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | DLABAJOVÁ Martina ( ALDE) | ZDECHOVSKÝ Tomáš ( PPE), POCHE Miroslav ( S&D), MARIAS Notis ( ECR), TARAND Indrek ( Verts/ALE), VALLI Marco ( EFDD), KAPPEL Barbara ( ENF) |
Committee Opinion | ITRE | ||
Committee Opinion | REGI |
Lead committee dossier:
Subjects
Events
The European Parliament decided to grant the Executive Director of the bio-based industries (BBI) Joint Undertaking discharge in respect of the implementation of the joint undertaking’s budget for the financial year 2017 and to approve the closure of the joint undertaking’s accounts.
Noting that the Court of Auditors considered that the annual accounts of the Joint Undertaking for the financial year 2017 accurately reflected the financial position of the Joint Undertaking as at 31 December 2017, as well as the results of its operations, Parliament adopted by 504 votes to 120, with 7 abstentions, a resolution containing a series of observations which form an integral part of the discharge decision.
General
Members noted that the maximum Union contribution to the activities of the Joint Undertaking is EUR 975 000 000, to be paid from Horizon 2020.
Budget and financial management
The Joint Undertaking’s annual accounts provide that the final 2017 budget is to be available for implementation and include commitment appropriations of EUR 92 900 000 and payment appropriations of EUR 91 600 000, the utilisation rates for commitment and payment appropriations of which were 97 % and 95 %, respectively. The payment appropriations were used mainly for the pre-financing of grant agreements resulting from the 2016 calls for proposals.
Parliament regretted that out of the minimum EUR 182 500 000 of cash contributions to be made by the industry members to the Joint Undertaking’s operational cost, only EUR 800 000 were paid by the end of 2017, having suspended the Commission EUR 50 000 000 of its cash contributions as a consequence.
Other observations
The resolution also contained a series of observations on procurement, recruitment, performance, internal audits and the legal framework. It noted in particular:
- by the end of 2017, the Joint Undertaking’s staff was almost complete, with 20 posts filled out of a total of 22 posts allocated to the Joint Undertaking by the staff establishment plan;
- that in 2017, the human resources unit continued to strengthen the legal framework paying particular attention to the application of the implementing rules of the Commission to the Joint Undertaking. Seven new implementing rules have been adopted by the governing board in 2017;
- the fact that the Joint Undertaking, together with six other joint undertakings, launched a common joint-undertaking call for expression of interest to select up to seven confidential counsellors that will set up a network of confidential counsellors.
The Committee on Budgetary Control adopted the report by Martina DLABAJOVÁ (ALDE, CZ) on discharge in respect of the implementation of the budget of the bio-based industries (BBI) Joint Undertaking for the financial year 2017.
The committee called on the European Parliament to grant the joint undertaking’s Executive Director discharge in respect of the implementation of the Joint Undertaking’s budget for the financial year 2017.
Noting that the Court of Auditors issued a statement of assurance as to the reliability of the accounts and the legality and regularity of the underlying transactions for the financial year 2017, Members called on Parliament to approve the closure of the joint undertaking’s accounts.
They made, however, a number of recommendations that need to be taken into account when the discharge is granted. They may be summarised as follows:
General
Members noted that the maximum Union contribution to the activities of the Joint Undertaking is EUR 975 000 000, to be paid from Horizon 2020. The industry members of the Joint Undertaking are to contribute resources of at least EUR 2 730 000 000 over the period of the Joint Undertaking, consisting of at least EUR 975 000 000 of in-kind and cash contributions to the Joint Undertaking’s operational activities and at least EUR 1 755 000 000 of in-kind contributions to implement additional activities outside the work plan of the Joint Undertaking.
They noted that 17 out of 82 retained proposals from the 2017 call for proposals were at the grant agreement preparation stage by the end of 2017. By early 2017, the Joint Undertaking programme will have a portfolio of 82 ongoing projects with a total of 932 participants from 30 countries with a total grant value of EUR 414 000 000.
Budget and financial management
The Joint Undertaking’s annual accounts provide that the final 2017 budget is to be available for implementation and include commitment appropriations of EUR 92 900 000 and payment appropriations of EUR 91 600 000, the utilisation rates for commitment and payment appropriations of which were 97 % and 95 %, respectively. The payment appropriations were used mainly for the pre-financing of grant agreements resulting from the 2016 calls for proposals.
Members regretted that out of the minimum EUR 182 500 000 of cash contributions to be made by the industry members to the Joint Undertaking’s operational cost, only EUR 800 000 were paid by the end of 2017, having suspended the Commission EUR 50 000 000 of its cash contributions as a consequence.
Other observations
The report also contained a series of observations on procurement, recruitment, performance, internal audits and the legal framework. It noted in particular:
- by the end of 2017, the Joint Undertaking’s staff was almost complete, with 20 posts filled out of a total of 22 posts allocated to the Joint Undertaking by the staff establishment plan;
- that in 2017, the human resources unit continued to strengthen the legal framework paying particular attention to the application of the implementing rules of the Commission to the Joint Undertaking. Seven new implementing rules have been adopted by the governing board in 2017;
- the fact that the Joint Undertaking, together with six other joint undertakings, launched a common joint-undertaking call for expression of interest to select up to seven confidential counsellors that will set up a network of confidential counsellors.
Having examined the revenue and expenditure accounts for the financial year 2016 and the balance sheet as at 31 December 2016 of the Bio-based Industries Joint Undertaking (BBI), as well as the Court of Auditors' report on the annual accounts of the Joint Undertaking for the financial year 2016, accompanied by the Joint Undertaking's replies to the Court's observations, the Council recommended the European Parliament to give a discharge to the Executive Director of the Joint Undertaking in respect of the implementation of the budget for the financial year 2016.
The Council welcomed the Court's opinion that, in all material respects, the Joint Undertaking's annual accounts present fairly its financial position as at 31 December 2017 and the results of its operations, its cash flows, and the changes in net assets for the year then ended, in accordance with the provisions of the Joint Undertaking's Financial Rules, and that the underlying transactions for 2017 are legal and regular in all material respects.
Nevertheless, one observation was made.
The Council called on the Joint Undertaking to consider limiting the number of proposals per topic by defining an indicative budget at topic level in the calls for proposals.
PURPOSE: presentation of the EU Court of Auditors’ report on the annual accounts of the Bio-based Industries Joint Undertaking for the financial year 2017, together with the Joint Undertaking’s replies.
CONTENT: the Court of Auditors carried out the audit on the accounts of the Bio-based Industries (BBI) Joint Undertaking.
In brief, the objective of the BBI Joint Undertaking is to implement a programme of research and innovation activities in Europe that will assess the availability of renewable biological resources that can be used for the production of bio-based materials, and on that basis support the establishment of sustainable bio-based value chains. Those activities should be carried out through collaboration between stakeholders along the entire bio-based value chain, including primary production and processing industries, consumer brands, SMEs, research and technology centres, and universities.
Statement of assurance and reliability of the accounts
The Court considered that:
- the Undertaking’s annual accounts present fairly, in all material respects, its financial position as at 31 December 2017 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of its Financial Regulation and the accounting rules adopted by the Commission’s accounting officer;
- the transactions underlying the annual accounts for the year ended 31 December 2017 are legal and regular in all material respects.
The report also makes a series of observations on the budgetary and financial management of the Undertaking, accompanied by the latter’s response. The main observations may be summarised as follows:
The Court’s observations
Financial management
The final 2017 budget included commitment appropriations of EUR 92.9 million and payment appropriations of EUR 91.6 million. The implementation rates for commitment and payment appropriations were 97 % and 95 %, respectively. Most of the payment appropriations made by the Joint Undertaking were pre-financing of grant agreements resulting from the 2016 call for proposals.
Out of the maximum of EUR 975 million of EU cash contribution to be allocated to the BBI Joint Undertaking over its life span, by the end of 2017, the EU contributed in cash a total amount of EUR 150.7 million.
The Commission (DG RTD) suspended EUR 50 million of its cash contributions to the Joint Undertaking. Although the Commission initiated in February 2017 an amendment of the BBI founding regulation in view to enable industry members also to provide their cash contributions at project level, there is a high risk that the industry members will not achieve the minimum amount of operational cash contributions by the end of the BBI programme.
Internal controls
The Joint Undertaking has set up reliable ex-ante control procedures based on financial and operational desk reviews. The situation at end of 2017 showed that the most important Internal Control Standards (ICS) were mostly implemented with some standards remaining to be fully implemented in 2018.
Based on an assessment of the Joint Undertaking’s internal control system and substantive testing of revenue, payment, grant and procurement operations, the audit results provided us with reasonable assurance that the overall residual error rate for the Joint Undertaking is below materiality.
At the end of 2017, the Commission’s common Horizon 2020 grant management and monitoring tools had not finished the specific developments needed for the processing of the Joint Undertaking’s in-kind contributions.
Leverage contributions
One of the main objectives of the Joint Undertaking is to leverage contributions from industry members in the area of its activities. The minimum leverage factor for both, operational and additional activities amounts to 2.8.
Joint Undertaking’s reply
Financial management
The JU stated that the European Commission initiated an amendment of the BBI’s founding regulation to allow the private partners to provide financial contributions also at project level. However, as the amendment entered into force only in February 2018, after the closure of four out of the seven calls for proposals planned until 2020 (inclusive), the risk of not achieving the minimum amount of financial (in- cash) contributions by the end of the BBI programme persists.
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2017, as part of the 2017 discharge procedure.
Analysis of the accounts of the Bio-based Industries Joint Undertaking - BBI .
CONTENT: the organisational governance of the EU consists of institutions, agencies and other EU bodies whose expenditure is included in the general budget of the Union.
This Commission document concerns the EU's consolidated accounts for the year 2017 and details how spending by the EU institutions and bodies was carried out. The consolidated annual accounts of the EU provide financial information on the activities of the institutions, agencies and other bodies of the EU from an accrual accounting and budgetary perspective.
It is the responsibility of the Commission's Accounting Officer to prepare the EU's consolidated annual accounts and ensure that they present fairly, in all material aspects, the financial position, the result of the operations and the cash flows of the EU institutions and bodies with a view to granting discharge.
Discharge procedure : the final step of a budget lifecycle is the discharge . It is the decision by which the European Parliament ‘ releases ’ the Commission from its responsibility for management of a given budget by marking the end of that budget's existence. It is granted by the European Parliament on the recommendation of the Council.
The decision is based in particular on the European Court of Auditors reports, in particular its annual report, in which the Court provides a Statement of Assurance (DAS) on the legality and regularity of transactions (payments and commitments).
The procedure results in the granting, postponement or refusal of discharge.
The final discharge report including specific recommendations to the Commission for action is adopted in plenary by the European Parliament and are subject to an annual follow up report in which the Commission outlines the concrete actions it has taken to implement the recommendations made.
All EU institutions and other agencies, bodies and joint undertakings are subject to their own discharge procedures.
BBI JU : the BBI, a Public-Private Partnership (PPP) set up in 2014 and located in Brussels (BE), was established in accordance with Council Regulation (EU) No 560/2014 establishing the Bio-based Industries Joint Undertaking. The BBI is dedicated to realising the European bio economy potential, turning biological residues and wastes into greener everyday products through innovative technologies and bio refineries, which are at the heart of the bio economy.
As regards the BBI’s accounts , these are presented in detail in the document published by the Joint Undertaking (please refer to the report on the final accounts of the BBI ).
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2017, as part of the 2017 discharge procedure.
Analysis of the accounts of the Bio-based Industries Joint Undertaking - BBI .
CONTENT: the organisational governance of the EU consists of institutions, agencies and other EU bodies whose expenditure is included in the general budget of the Union.
This Commission document concerns the EU's consolidated accounts for the year 2017 and details how spending by the EU institutions and bodies was carried out. The consolidated annual accounts of the EU provide financial information on the activities of the institutions, agencies and other bodies of the EU from an accrual accounting and budgetary perspective.
It is the responsibility of the Commission's Accounting Officer to prepare the EU's consolidated annual accounts and ensure that they present fairly, in all material aspects, the financial position, the result of the operations and the cash flows of the EU institutions and bodies with a view to granting discharge.
Discharge procedure : the final step of a budget lifecycle is the discharge . It is the decision by which the European Parliament ‘ releases ’ the Commission from its responsibility for management of a given budget by marking the end of that budget's existence. It is granted by the European Parliament on the recommendation of the Council.
The decision is based in particular on the European Court of Auditors reports, in particular its annual report, in which the Court provides a Statement of Assurance (DAS) on the legality and regularity of transactions (payments and commitments).
The procedure results in the granting, postponement or refusal of discharge.
The final discharge report including specific recommendations to the Commission for action is adopted in plenary by the European Parliament and are subject to an annual follow up report in which the Commission outlines the concrete actions it has taken to implement the recommendations made.
All EU institutions and other agencies, bodies and joint undertakings are subject to their own discharge procedures.
BBI JU : the BBI, a Public-Private Partnership (PPP) set up in 2014 and located in Brussels (BE), was established in accordance with Council Regulation (EU) No 560/2014 establishing the Bio-based Industries Joint Undertaking. The BBI is dedicated to realising the European bio economy potential, turning biological residues and wastes into greener everyday products through innovative technologies and bio refineries, which are at the heart of the bio economy.
As regards the BBI’s accounts , these are presented in detail in the document published by the Joint Undertaking (please refer to the report on the final accounts of the BBI ).
Documents
- Results of vote in Parliament: Results of vote in Parliament
- Debate in Parliament: Debate in Parliament
- Decision by Parliament: T8-0287/2019
- Committee report tabled for plenary: A8-0103/2019
- Supplementary non-legislative basic document: 05827/2019
- Amendments tabled in committee: PE634.562
- Committee draft report: PE626.826
- Court of Auditors: opinion, report: OJ C 452 14.12.2018, p. 0010
- Court of Auditors: opinion, report: N8-0002/2019
- Non-legislative basic document: COM(2018)0521
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2018)0521
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2018)0521 EUR-Lex
- Court of Auditors: opinion, report: OJ C 452 14.12.2018, p. 0010 N8-0002/2019
- Committee draft report: PE626.826
- Amendments tabled in committee: PE634.562
- Supplementary non-legislative basic document: 05827/2019
Votes
A8-0103/2019 - Martina Dlabajová - Résolution 26/03/2019 17:58:06.000 #
A8-0103/2019 - Martina Dlabajová - Résolution #
Amendments | Dossier |
9 |
2018/2214(DEC)
2019/01/30
CONT
9 amendments...
Amendment 1 #
Proposal for a decision 1 Citation 4 — having regard to the Council’s recommendation of
Amendment 2 #
Proposal for a decision 1 Citation 8 a (new) - having regard to Council Regulation (EU) 2018/121 of 23 January 2018 amending Regulation (EU) No 560/2014 establishing the Bio-based Industries Joint Undertaking,
Amendment 3 #
Proposal for a decision 1 Paragraph 1 Amendment 4 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 5 #
Proposal for a decision 2 Citation 8 a (new) - having regard to Council Regulation (EU) 2018/121 of 23 January 2018 amending Regulation (EU) No 560/2014 establishing the Bio-based Industries Joint Undertaking,
Amendment 6 #
Motion for a resolution Recital A A. whereas the Bio-based Industries Joint Undertaking (the ‘Joint Undertaking’) was established as a public-private partnership by the Council Regulation (EU) No 560/20141a for a period of 10 years with the aim of bringing together all relevant stakeholders and contributing to establishing the Union as a key player in research, demonstration and deployment of advanced bio-based products and biofuels; _________________ 1a amended by Council Regulation (EU) 2018/121 of 23 January 2018
Amendment 7 #
Motion for a resolution Paragraph 9 9. Regrets that out of the minimum EUR 182 500 000 of cash contributions to be made by the industry members to the Joint Undertaking’s operational cost, only EUR 800 000 were paid by the end of 2017, having suspended the Commission EUR 50 000 000 of its cash contributions as a consequence; observes that there is a high risk that the minimum will not be achieved by the end of the Joint Undertaking’s programme;
Amendment 8 #
Motion for a resolution Paragraph 16 16. Notes that by the end of 2017, the Joint Undertaking’s staff was almost complete, with 20 posts filled out of a total of 22 posts allocated to the Joint Undertaking by the staff establishment plan; takes note that the Joint Undertaking recruited 2 temporary agents and 2 contract agents during 2017; notes, moreover, that in order to address additional workload, the Commission authorised the Joint Undertaking to split one position in the establishment plan into one temporary agent with a lower grade and one additional contract agent; takes note that that measure is still pending on the approval of the Governing Board;
Amendment 9 #
Motion for a resolution Paragraph 22 22. Notes that the Commission’s Interim Evaluation on the Joint Undertaking’s activities from 2014 to 2016 was carried out, an
source: 634.562
|
History
(these mark the time of scraping, not the official date of the change)
docs/0 |
|
events/0/date |
Old
2018-06-28T00:00:00New
2018-06-27T00:00:00 |
events/5/docs |
|
committees/0/shadows/3 |
|
docs/1/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE626.826New
https://www.europarl.europa.eu/doceo/document/CONT-PR-626826_EN.html |
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE634.562New
https://www.europarl.europa.eu/doceo/document/CONT-AM-634562_EN.html |
events/1/type |
Old
Committee referral announced in Parliament, 1st reading/single readingNew
Committee referral announced in Parliament |
events/2/type |
Old
Vote in committee, 1st reading/single readingNew
Vote in committee |
events/3/type |
Old
Committee report tabled for plenary, single readingNew
Committee report tabled for plenary |
events/4 |
|
events/4 |
|
events/4/docs |
|
events/5 |
|
events/5 |
|
events/6 |
|
events/6/type |
Old
Decision by Parliament, 1st reading/single readingNew
Decision by Parliament |
procedure/Modified legal basis |
Rules of Procedure EP 159
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
docs/1/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE626.826New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE626.826 |
docs/2/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE634.562New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE634.562 |
events/3/docs/0/url |
Old
http://www.europarl.europa.eu/doceo/document/A-8-2019-0103_EN.htmlNew
https://www.europarl.europa.eu/doceo/document/A-8-2019-0103_EN.html |
events/4/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20190326&type=CRENew
https://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20190326&type=CRE |
events/5/docs/0/url |
Old
http://www.europarl.europa.eu/doceo/document/TA-8-2019-0287_EN.htmlNew
https://www.europarl.europa.eu/doceo/document/TA-8-2019-0287_EN.html |
events/7 |
|
procedure/final |
|
procedure/stage_reached |
Old
Procedure completed, awaiting publication in Official JournalNew
Procedure completed |
events/3/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2019-0103&language=ENNew
http://www.europarl.europa.eu/doceo/document/A-8-2019-0103_EN.html |
events/5/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2019-0287New
http://www.europarl.europa.eu/doceo/document/TA-8-2019-0287_EN.html |
committees/0 |
|
committees/0 |
|
activities |
|
commission |
|
committees/0 |
|
committees/0 |
|
committees/1 |
|
committees/1 |
|
committees/2 |
|
committees/2 |
|
docs |
|
events |
|
links |
|
other |
|
procedure/Modified legal basis |
Rules of Procedure EP 159
|
procedure/dossier_of_the_committee |
Old
CONT/8/14371New
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Procedure completed, awaiting publication in Official Journal |
procedure/subject |
Old
New
|
procedure/title |
Old
2017 discharge: Bio-based Industries Joint Undertaking (BBI Joint Undertaking)New
2017 discharge: Bio-based Industries Joint Undertaking (BBI Joint Undertaking) |
activities/0/commission/0 |
|
activities/1 |
|
other/0 |
|
procedure/dossier_of_the_committee |
CONT/8/14371
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
committees/0/date |
2018-07-25T00:00:00
|
committees/0/rapporteur |
|
committees/0/shadows |
|
activities |
|
committees |
|
links |
|
other |
|
procedure |
|